Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19

Respirology. 2021 Jun;26(6):612-615. doi: 10.1111/resp.14062. Epub 2021 Apr 19.

John A Mackintosh¹, Laura Glenn^{2

3}, Hayley Barnes⁴, Emily Dunn⁵, Sandra Bancroft¹, Taryn Reddy⁶, Alan K Y Teoh^{2

3}, Lauren Troy², Helen Jo², Monika Geis², Ian Glaspole⁴, Christopher Grainge⁵, Tamera J Corte^{2

3}, Daniel C Chambers^{1

7}, Peter Hopkins^{1

7}

¹ Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.
² Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
³ Faculty of Medicine and Health, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.
⁴ Department of Respiratory and Sleep Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
⁵ Department of Respiratory Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
⁶ Department of Medical Imaging, The Prince Charles Hospital, Brisbane, Queensland, Australia.
⁷ Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

No abstract available

Keywords: interstitial lung disease; multidisciplinary meeting; pulmonary fibrosis.

Publication types